Interactions of Alginate-Deferoxamine Conjugates With Blood Components and Their Antioxidation in the Hemoglobin Oxidation Model

While deferoxamine (DFO) has long been used as an FDA-approved iron chelator, its proangiogenesis ability attracts increasing number of research interests. To address its drawbacks such as short plasma half-life and toxicity, polymeric conjugated strategy has been proposed and shown superiority. Owi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Tong, Guo, Xi, Zhong, Rui, Wang, Chengwei, Liu, Hao, Li, Hao, Ma, Lu, Guan, Junwen, You, Chao, Tian, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026261/
https://www.ncbi.nlm.nih.gov/pubmed/32117933
http://dx.doi.org/10.3389/fbioe.2020.00053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026261/
https://www.ncbi.nlm.nih.gov/pubmed/32117933
http://dx.doi.org/10.3389/fbioe.2020.00053

Ejemplares similares